Scientists have identified that a protein called TPPP3 makes ovarian cancer cells resistant to chemotherapy. Scientists stated that TPPP3 makes cancer cells adapt to chemotherapy by altering their internal structure, enabling them to survive and resist treatment. "When we remove it, we weaken the cell's defences and allow chemotherapy to work more effectively," one of the researchers said.